tbuckley/cabot-search huggingface dataset:
Cross-phenotype analysis of Immunochip data identifies <i>KDM4C</i> as a relevant <i>locus</i> for the development of systemic vasculitis
Authors: Lourdes Ortiz-Fernández, Francisco David Carmona, Raquel López-Mejías, Maria Francisca González-Escribano, Paul A Lyons, Ann W Morgan, Amr H Sawalha, Peter A Merkel, Kenneth G C Smith, Miguel A González-Gay, Javier Martín
Journal: Annals of the Rheumatic Diseases (2018)

Systemic vasculitides represent a heterogeneous group of rare complex diseases of the blood vessels with a poorly understood aetiology. To investigate the shared genetic component underlying their predisposition, we performed the first cross-phenotype meta-analysis of genetic data from different clinically distinct patterns of vasculitis.
Universal SLAMF7-Specific CAR T-Cells As Treatment for Multiple Myeloma
Authors: Rohit Mathur, Zheng Zhang, Jin He, Roman Galetto, Agnès Gouble, Isabelle Chion-Sotinel, Stéphanie Filipe, Annabelle Gariboldi, Tanooha Veeramachaneni, Elisabet E. Manasanch, Sheeba K. Thomas, Hans C. Lee, Krina K. Patel, Donna M. Weber, R. Eric Davis, Robert J. Orlowski, Julianne Smith, Jing Yang, Sattva S. Neelapu
Journal: Blood (2017)
The Jun/miR-22/HuR regulatory axis contributes to tumourigenesis in colorectal cancer
Authors: Yanqing Liu, Xiaorui Chen, Rongjie Cheng, Fei Yang, Mengchao Yu, Chen Wang, Shufang Cui, Yeting Hong, Hongwei Liang, Minghui Liu, Chihao Zhao, Meng Ding, Wu Sun, Zhijian Liu, Feng Sun, Chenyu Zhang, Zhen Zhou, Xiaohong Jiang, Xi Chen
Journal: Molecular Cancer (2018)

Colorectal cancer (CRC) is a severe health problem worldwide. Clarifying the mechanisms for the deregulation of oncogenes and tumour suppressors in CRC is vital for its diagnosis, treatment, prognosis and prevention. Hu antigen R (HuR), which is highly upregulated in CRC, functions as a pivotal oncogene to promote CRC progression. However, the underlying cause of its dysregulation is poorly understood. In CRC tissue sample pairs, HuR protein levels were measured by Western blot and immunohistochemical (IHC) staining, respectively. HuR mRNA levels were also monitored by qRT-PCR. Combining meta-analysis and microRNA (miRNA) target prediction software, we predicted miRNAs that targeted HuR. Pull-down assay, Western blot and luciferase assay were utilized to demonstrate the direct binding of miR-22 on HuR's 3'-UTR. The biological effects of HuR and miR-22 were investigated both in vitro by CCK-8, EdU and Transwell assays and in vivo by a xenograft mice model. JASPAR and SABiosciences were used to predict transcriptional factors that could affect miR-22. Luciferase assay was used to explore the validity of putative Jun binding sites for miR-22 regulation. ChIP assay was performed to test the Jun's occupancy on the C17orf91 promoter. We observed a significant upregulation of HuR in CRC tissue pairs and confirmed the oncogenic function of HuR both in vitro and in vivo. We found that an important tumour-suppressive miRNA, miR-22, was significantly downregulated in CRC tissues and inversely correlated with HuR in both CRC tissues and CRC cell lines. We demonstrated that miR-22 directly bound to the 3'-UTR of HuR and led to inhibition of HuR protein, which repressed CRC proliferation and migration in vitro and decelerated CRC xenografted tumour growth in vivo. Furthermore, we found that the onco-transcription factor Jun could inhibit the transcription of miR-22. Our findings highlight the critical roles of the Jun/miR-22/HuR regulatory axis in CRC progression and may provide attractive potential targets for CRC prevention and treatment.
Type 2 innate lymphoid cells expressing death receptor 3 are increased in airway of mild atopic asthmatic subject following allergen inhalation challenge
Authors: Kentaro Machida, Adrian Baatjes, Richard Watson, Tara Scime, Gail M. Gauvreau, Paul M. O'Byrne, Roma Sehmi
Journal: Journal of Allergy and Clinical Immunology (2018)
Low Incidence of Osteonecrosis in Childhood Acute Lymphoblastic Leukemia Treated With ALL-97 and ALL-02 Study of Japan Association of Childhood Leukemia Study Group
Authors: Kenichi Sakamoto, Toshihiko Imamura, Kentaro Kihira, Koji Suzuki, Hisashi Ishida, Hiromi Morita, Miyako Kanno, Takeshi Mori, Hidefumi Hiramatsu, Kousaku Matsubara, Kiminori Terui, Yoshihiro Takahashi, So-ichi Suenobu, Daiichiro Hasegawa, Yoshiyuki Kosaka, Koji Kato, Akiko Moriya-Saito, Atsushi Sato, Hirohide Kawasaki, Keiko Yumura-Yagi, Junichi Hara, Hiroki Hori, Keizo Horibe
Journal: Journal of Clinical Oncology (2018)

Purpose Osteonecrosis (ON) is a serious complication of the treatment of childhood acute lymphoblastic leukemia (ALL); however, data relating to ON in Asian pediatric patients with ALL are scarce. Therefore, we performed a retrospective analysis of cohorts of Japanese patients with ALL to clarify the incidence, clinical characteristics, and risk factors of ON. Patients and Methods The incidence and characteristics of ON were determined in patients with ALL (n = 1,662) enrolled in two studies from the Japan Association of Childhood Leukemia Study (JACLS) group (n = 635 and n = 1,027 patients treated with the ALL-97 and ALL-02 protocols, respectively). Results In total, 24 of 1,662 patients suffered from ON, of which 12 of 635 and 12 of 1,027 patients were treated with the ALL-97 and the ALL-02 protocol, respectively. Of the 24 patients, 23 were older than 10 years. In multivariate analysis, age (≥ 10 years) was the sole significant risk factor for ON ( P < .001). Separate evaluation of patients ≥ 10 years of age indicated a 5-year cumulative incidence of ON of 7.2% (95% CI, 4.0% to 12.6%) and 5.9% (95% CI, 3.3% to 10.4%) in the ALL-97 and the ALL-02 protocol, respectively, which was lower than reported previously, despite an administration of dexamethasone (DEX) similar to that in comparable studies; however, concomitant administration of DEX and l-asparaginase was reduced in the JACLS protocols. Conclusion We identified a low frequency of ON in the JACLS ALL-97 and ALL-02 studies. Although the sole risk factor for ON was age (≥ 10 years), even among high-risk patients, ON incidence was significantly lower than that reported in previous studies. These results suggest that, not only the total amount of DEX, but also how DEX and l-asparaginase are administered, which affects the clearance of DEX, may be associated with ON incidence in patients with ALL.
MRD-Response Driven Phase I/II Study for Newly Diagnosed Multiple Myeloma Patients Using Higher Doses of Twice-Weekly Carfilzomib (45 and 56 mg/m2) in Combination with Lenalidomide and Dexamethasone
Authors: Neha Korde, Donna Mastey, Sham Mailankody, Hani Hassoun, Alexander M. Lesokhin, Eric L. Smith, Nikoletta Lendvai, Malin Hultcrantz, Elizabet Tavitian, Meghan Salcedo, Allison Sams, Victoria Diab, David J. Chung, Michael Scordo, Oscar B Lahoud, Heather J. Landau, Maria E Arcila, Sergio Giralt, Caleb Ho, Mikhail Roshal, Sean M Devlin, Ahmet Dogan, Ola Landgren
Journal: Blood (2018)
Radiation enhances engraftment of mesenchymal stem cells in murine 4T1 tumors
Authors: Ann Klopp, Erika Spaeth, Jennifer Dembinski, Ray Meyn, Anupama Munshi, James Cox, Michael Andreeff, Frank Marini
Journal: Cancer Research (2007)

1329  Mesenchymal stem cells (MSCs) migrate and proliferate within tumors as well as at other sites of inflammation. MSCs engineered to express IFN-β have been shown to reduce tumor burden and extend survival in murine breast cancer, leukemia and glioma models. Clinical trials are under development but this strategy could be limited by non-specific migration of MSCs to other sites of inflammation. Radiation increases expression of inflammatory cytokines and could be used to enhance engraftment of MSCs in tumors. To investigate this, we implanted 2 x 105 4T1 cells expressing renilla luciferase into bilateral hindlimbs of Balb/C mice. Nine days later, a dose of 1 or 2 Gy was delivered with 60Co to the right hindlimb. Control mice were not irradiated. Ten days after tumor implantation, 4 x 105 MSCs transduced with an adenoviral vector expressing firefly luciferase were injected intravenously. Mice were then serially monitored with bioluminescent imaging for expression of renilla and firefly luciferase.   Two days after radiation, levels of MSC engraftment using luciferase imaging were 25% higher in tumors receiving 2 Gy (p=0.004, two-sided t-test) and 22% higher in tumors treated to 1 Gy (p=0.03) as compared to contralateral unirradiated tumors. Levels of MSC engraftment were the same in the right and left leg in unirradiated mice. Radiation did not appear to contribute to engraftment in the contralateral limb as MSC levels were similar in the unirradiated limb of mice treated with radiation and in unirradiated mice. At 4 and 6 days after treatment, there were no statistically significant differences in absolute levels of MSC engraftment. However, if normalization to renilla luciferase was performed to account for tumor shrinkage in response to radiation, there was a relative increase in MSCs in tumors radiated to 2 Gy at 4 days (1.4 fold higher in radiated limb, p=0.08) and 6 days (1.5 fold higher in radiated limb, p=0.003) after treatment. In conclusion, MSCs preferentially engraft in 4T1 tumors after a single low dose fraction of radiation. Additional experiments to maximize this effect are in progress. The concept proposed could be a useful strategy to selectively enhance delivery of anti-tumor agents in MSC to tumor sites.
Development of JCARH125: Optimization of a Fully Human Anti-Bcma CAR for Use in the Treatment of Multiple Myeloma
Authors: Kim Harrington, Rebecca Wu, Collin Hauskins, Rupesh Amin, Thomas Long, Aye Chen, Ayu Rahardjo, Casey Thayer, Garnet Navvaro, Madelyn Myers, Jon Jones, Alex Baturevych, Stan Morkowski, Ruth Salmon, Christopher J Bond, Mette Staehr, Terence J Purdon, Reed Masakayan, Cheng Liu, Hong Liu, Yiyang Xu, Pei Wang, Margot Pont, Damian J. Green, Renier J. Brentjens, Eric L Smith, Blythe Duke Sather
Journal: Blood (2017)
Impact of Mutant Haemopoietic Transcription Factor GATA1s on Haemopoiesis
Authors: Paresh Vyas, Gaetan Juban, Nathalie Sakakini, Kelly Soady, Hedia Chagraoui, Bilyana Stoilova, Catherine Garnett, Ludovic Lhermitte, Elena Karkoulia, John Strouboulis, Catherine Porcher, Irene Roberts
Journal: Blood (2017)
T Cell Costimulation Blockade with Abatacept Nearly Eliminates Early Severe Acute Graft Versus Host Disease after HLA-Mismatched (7/8 HLA Matched) Unrelated Donor Transplant, with a Favorable Impact on Disease-Free and Overall Survival
Authors: Ben Watkins, Muna Qayed, Brandi Bratrude, Kayla Betz, Melanie Brown, James Rhodes, Shauna Sinclair, Yvonne Suessmuth, Alison Yu, Kyle Hebert, Marcelo C. Pasquini, Sung W. Choi, Jeffrey Davis, Christine Duncan, Roger Giller, Michael Grimley, Andrew C Harris, David A. Jacobsohn, Nahal Lalefar, Maxim Norkin, Michael A Pulsipher, Shalini Shenoy, Bruce Blazar, Amelia Langston, John T Horan, Leslie Kean
Journal: Blood (2017)
“Truth be told” – Semantic memory as the scaffold for veridical communication
Authors: Brett K. Hayes, Siddharth Ramanan, Muireann Irish
Journal: Behavioral and Brain Sciences (2018)

Abstract Theoretical accounts placing episodic memory as central to constructive and communicative functions neglect the role of semantic memory. We argue that the decontextualized nature of semantic schemas largely supersedes the computational bottleneck and error-prone nature of episodic memory. Rather, neuroimaging and neuropsychological evidence of episodic-semantic interactions suggest that an integrative framework more accurately captures the mechanisms underpinning social communication.
Donor Age Determines Outcome in Acute Leukemia Patients Undergoing Haploidentical Hematopoietic Cell Transplantation
Authors: Jonathan Canaani, Bipin N. Savani, Myriam Labopin, Xiao Jun Huang, Fabio Ciceri, William Arcese, Yener Koc, Johanna Tischer, Didier Blaise, Zafer Gulbas, Maria Teresa Van Lint, Benedetto Bruno, Mohamad Mohty, Arnon Nagler
Journal: Blood (2017)
A Prospective Phase II of Daratumumab in Previously-Treated Systemic Light-Chain (AL) Amyloidosis
Authors: Murielle Roussel, Anne-Marie Stoppa, Aurore Perrot, Lionel Karlin, Bertrand Arnulf, Margaret Macro, Antoine Huart, Laurent Frenzel, Pierre Morel, Eileen Boyle, Veronique Dorvaux, Giampaolo Merlini, Giovanni Palladini, David Lavergne, Frank Bridoux, Arnaud Jaccard
Journal: Blood (2017)
Increased Risk of Toxicity with Novel PI3K Delta Inhibitor Combinations Compared with Standard Use in Non-Hodgkin Lymphoma Patients
Authors: Annalynn Williams, Elizabeth Baloga, Andrea Baran, Margaret Helber, Jeremiah Moore, Carla Casulo, Patrick M. Reagan, Jonathan W. Friedberg, Clive S Zent, Paul M. Barr
Journal: Blood (2017)
Targeting DNA Repair in Prostate Cancer
Authors: Wassim Abida, Charles L. Sawyers
Journal: Journal of Clinical Oncology (2018)

Article Tools UNDERSTANDING THE PATHWAY Article Tools OPTIONS & TOOLS Export Citation Track Citation Add To Favorites Rights & Permissions COMPANION ARTICLES Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012. December 20, 2017 ARTICLE CITATION DOI: 10.1200/JCO.2017.76.6592 Journal of Clinical Oncology - published online before print January 25, 2018 PMID: 29369701 Targeting DNA Repair in Prostate Cancer Wassim AbidaxWassim AbidaSearch for articles by this author and Charles L. SawyersxCharles L. SawyersSearch for articles by this author Show More Wassim Abida, Memorial Sloan Kettering Cancer Center, New York, NY; and Charles L. Sawyers, Memorial Sloan Kettering Cancer Center, New York, NY; and Howard Hughes Medical Institute, Chevy Chase, MD https://doi.org/10.1200/JCO.2017.76.6592 First Page Full Text PDF Figures and Tables Supplements © 2018 by American Society of Clinical Oncology Companion Targeting Androgen Receptor and DNA Repair in Metastatic Castration-Resistant Prostate Cancer: Results From NCI 9012
Lenalidomide Enhances Anti-BCMA Chimeric Antigen Receptor T Cell Function Against Multiple Myeloma
Authors: Melissa Works, Neha Soni, Collin Hauskins, Catherine Sierra, Alex Baturevych, Jon Jones, Wendy Curtis, Timothy Johnstone, David Kugler, Yue Jiang, Ron Hause, Blythe Duke Sather, Ruth Salmon, Michael Ports
Journal: Blood (2017)
Ring1A and Ring1B inhibit expression of Glis2 to maintain murine MOZ-TIF2 AML stem cells
Authors: Haruko Shima, Emi Takamatsu-Ichihara, Mika Shino, Kazutsune Yamagata, Takuo Katsumoto, Yukiko Aikawa, Shuhei Fujita, Haruhiko Koseki, Issay Kitabayashi
Journal: Blood (2018)
Sleep to be social: The critical role of sleep and memory for social interaction
Authors: Susanne Diekelmann, Frieder M. Paulus, Sören Krach
Journal: Behavioral and Brain Sciences (2018)

Abstract Humans are highly social animals who critically need to remember information from social episodes in order to successfully navigate future social interactions. We propose that such episodic memories about social encounters are processed during sleep, following the learning experience, with sleep abstracting and consolidating social gist knowledge (e.g., beliefs, first impressions, or stereotypes) about others that supports relationships and interpersonal communication.
EWS/FLI Confers Tumor Cell Synthetic Lethality to CDK12 Inhibition in Ewing Sarcoma
Authors: Amanda Balboni Iniguez, Björn Stolte, Emily Jue Wang, Amy Saur Conway, Gabriela Alexe, Neekesh V. Dharia, Nicholas Kwiatkowski, Tinghu Zhang, Brian J. Abraham, Jaume Mora, Peter Kalev, Alan Leggett, Dipanjan Chowdhury, Cyril H. Benes, Richard A. Young, Nathanael S. Gray, Kimberly Stegmaier
Journal: Cancer Cell (2018)
Exogenous Gene Transmission of Isocitrate Dehydrogenase 2 Mimics Ischemic Preconditioning Protection
Authors: Alexander L. Kolb, Peter R. Corridon, Shijun Zhang, Weimin Xu, Frank A. Witzmann, Jason A. Collett, George J. Rhodes, Seth Winfree, Devin Bready, Zechariah J. Pfeffenberger, Jeremy M. Pomerantz, Takashi Hato, Glenn T. Nagami, Bruce A. Molitoris, David P. Basile, Simon J. Atkinson, Robert L. Bacallao
Journal: Journal of the American Society of Nephrology (2018)

Ischemic preconditioning confers organ-wide protection against subsequent ischemic stress. A substantial body of evidence underscores the importance of mitochondria adaptation as a critical component of cell protection from ischemia. To identify changes in mitochondria protein expression in response to ischemic preconditioning, we isolated mitochondria from ischemic preconditioned kidneys and sham-treated kidneys as a basis for comparison. The proteomic screen identified highly upregulated proteins, including NADP+-dependent isocitrate dehydrogenase 2 (IDH2), and we confirmed the ability of this protein to confer cellular protection from injury in murine S3 proximal tubule cells subjected to hypoxia. To further evaluate the role of IDH2 in cell protection, we performed detailed analysis of the effects of Idh2 gene delivery on kidney susceptibility to ischemia-reperfusion injury. Gene delivery of IDH2 before injury attenuated the injury-induced rise in serum creatinine ( P &lt;0.05) observed in controls and increased the mitochondria membrane potential ( P &lt;0.05), maximal respiratory capacity ( P &lt;0.05), and intracellular ATP levels ( P &lt;0.05) above those in controls. This communication shows that gene delivery of Idh2 can confer organ-wide protection against subsequent ischemia-reperfusion injury and mimics ischemic preconditioning.
Elotuzumab Plus Lenalidomide/Dexamethasone (ELd) Vs Ld in Patients with Newly Diagnosed Multiple Myeloma: Phase 2, Randomized, Open-Label Study in Japan
Authors: Naoki Takezako, Kensuke Ohta, Hiroshi Handa, Mitsuo Hori, Gen Kinoshita, Suresh Shelat, Masafumi Miyoshi, Kohmei Kubo
Journal: Blood (2017)
The Practice of Respect in the ICU
Authors: Samuel M. Brown, Elie Azoulay, Dominique Benoit, Terri Payne Butler, Patricia Folcarelli, Gail Geller, Ronen Rozenblum, Ken Sands, Lauge Sokol-Hessner, Daniel Talmor, Kathleen Turner, Michael D. Howell
Journal: American Journal of Respiratory and Critical Care Medicine (2018)

Although "respect" and "dignity" are intuitive concepts, little formal work has addressed their systematic application in the ICU setting. After convening a multidisciplinary group of relevant experts, we undertook a review of relevant literature and collaborative discussions focused on the practice of respect in the ICU. We report the output of this process, including a summary of current knowledge, a conceptual framework, and a research program for understanding and improving the practice of respect and dignity in the ICU. We separate our report into findings and proposals. Findings include the following: 1) dignity and respect are interrelated; 2) ICU patients and families are vulnerable to disrespect; 3) violations of respect and dignity appear to be common in the ICU and overlap substantially with dehumanization; 4) disrespect may be associated with both primary and secondary harms; and 5) systemic barriers complicate understanding and the reliable practice of respect in the ICU. Proposals include: 1) initiating and/or expanding a field of research on the practice of respect in the ICU; 2) treating "failures of respect" as analogous to patient safety events and using existing quality and safety mechanisms for improvement; and 3) identifying both benefits and potential unintended consequences of efforts to improve the practice of respect. Respect and dignity are important considerations in the ICU, even as substantial additional research remains to be done.
Epidemiologic Evidence That Excess Body Weight Increases Risk of Cervical Cancer by Decreased Detection of Precancer
Authors: Megan A. Clarke, Barbara Fetterman, Li C. Cheung, Nicolas Wentzensen, Julia C. Gage, Hormuzd A. Katki, Brian Befano, Maria Demarco, John Schussler, Walter K. Kinney, Tina R. Raine-Bennett, Thomas S. Lorey, Nancy E. Poitras, Philip E. Castle, Mark Schiffman
Journal: Journal of Clinical Oncology (2018)

Purpose Obesity has been inconsistently linked to increased cervical cancer incidence and mortality; however, the effect of obesity on cervical screening has not been explored. We investigated the hypothesis that increased body mass might decrease detection of cervical precancer and increase risk of cervical cancer even in women undergoing state-of-the-art screening. Methods We conducted a retrospective cohort study of 944,227 women age 30 to 64 years who underwent cytology and human papillomavirus DNA testing (ie, cotesting) at Kaiser Permanente Northern California (January 2003 to December 2015). Body mass index was categorized as normal/underweight (&lt; 25 kg/m 2 ), overweight (25 to &lt; 30 kg/m 2 ), or obese (≥ 30 kg/m 2 ). We estimated 5-year cumulative risks of cervical precancer and cancer by category of body mass index using logistic Weibull survival models. Results We observed lower risk of cervical precancer (n = 4,489) and higher risk of cervical cancer (n = 490) with increasing body mass index. Specifically, obese women had the lowest 5-year risk of precancer (0.51%; 95% CI, 0.48% to 0.54% v 0.73%; 95% CI, 0.70% to 0.76% in normal/underweight women; P trend &lt; .001). In contrast, obese women had the highest 5-year risk of cancer (0.083%; 95% CI, 0.072% to 0.096% v 0.056%; 95% CI, 0.048% to 0.066% in normal/underweight women; P trend &lt; .001). Results were consistent in subgroups defined by age (30 to 49 v 50 to 64 years), human papillomavirus status (positive v negative), and histologic subtype (glandular v squamous). Approximately 20% of cervical cancers could be attributed to overweight or obesity in the women in our study who underwent routine cervical screening. Conclusion In this large, screened population, overweight and obese women had an increased risk of cervical cancer, likely because of underdiagnosis of cervical precancer. Improvements in equipment and/or technique to assure adequate sampling and visualization of women with elevated body mass might reduce cervical cancer incidence.
Conversion is a risk factor for postoperative anastomotic leak in rectal cancer patients - A retrospective cohort study
Authors: Xuan-hui Liu, Xian-rui Wu, Chi Zhou, Xiao-bin Zheng, Jia Ke, Hua-shan Liu, Tuo Hu, Yu-feng Chen, Xiao-wen He, Xiao-sheng He, Yong-le Chen, Yi-feng Zou, Jian-ping Wang, Xiao-jian Wu, Ping Lan
Journal: International Journal of Surgery (2018)
Diagnosis and management of Duchenne muscular dystrophy, part 3: primary care, emergency management, psychosocial care, and transitions of care across the lifespan
Authors: David J Birnkrant, Katharine Bushby, Carla M Bann, Susan D Apkon, Angela Blackwell, Mary K Colvin, Linda Cripe, Adrienne R Herron, Annie Kennedy, Kathi Kinnett, James Naprawa, Garey Noritz, James Poysky, Natalie Street, Christina J Trout, David R Weber, Leanne M Ward
Journal: The Lancet Neurology (2018)
Regeneration of Tumor Antigen Specific CTLs Utilizing iPSC Technology for Off-the-Shelf Immunotherapy
Authors: Takuya Maeda, Seiji Nagano, Kyoko Masuda, Toshio Kitawaki, Keisuke Kataoka, Seishi Ogawa, Norimitsu Kadowaki, Akifumi Kondo Takaori, Hiroshi Kawamoto
Journal: Blood (2016)
Lenalidomide Maintenance Significantly Improves Outcomes Compared to Observation Irrespective of Cytogenetic Risk: Results of the Myeloma XI Trial
Authors: Graham Jackson, Faith E Davies, Charlotte Pawlyn, David Cairns, Alina Striha, Anna Hockaday, Inga Sakauskiene, John R Jones, Bhuvan Kishore, Mamta Garg, Cathy Williams, Kamaraj Karunanithi, Jindriska Lindsay, Matthew W Jenner, Gordon Cook, Martin F Kaiser, Mark T Drayson, Roger G Owen, Nigel H. Russell, Walter M Gregory, Gareth J. Morgan
Journal: Blood (2017)
Atorvastatin May Reverse Corticosteroid-Resistant Immune Thrombocytopenia Via Improving Impaired Bone Marrow Endothelial Cells
Authors: Yuan Kong, Xie-Na Cao, Xiaohui Zhang, Min-Min Shi, Yue-Yun Lai, Yu Wang, Lan-Ping Xu, Ying-Jun Chang, Xiao-Jun Huang
Journal: Blood (2017)